The YouTuber suggests buying Inogen, a medical device maker specializing in portable oxygen concentrators. He notes the stock is significantly below its 52-week high and technically oversold. Despite recent sales hits from the pandemic and Medicare changes, the company has a pristine balance sheet with substantial cash, strong recurring revenue growth, and significant long-term growth potential in POC penetration and increasing demand for respiratory devices.
“The company has 245 million dollars in cash and no debt that means a third of the market value of this stock is backed by cash.”